Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees

被引:106
作者
Day, DJ
Speiser, PW
Schulze, E
Bettendorf, M
Fitness, J
Barany, F
White, PC
机构
[1] CORNELL UNIV,DEPT MICROBIOL,HEARST MICROBIOL RES CTR,COLL MED,NEW YORK,NY 10021
[2] VICTORIA UNIV WELLINGTON,SCH BIOL SCI,WELLINGTON,NEW ZEALAND
[3] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT PEDIAT,MANHASSET,NY 11030
[4] UNIV HEIDELBERG,INST PHARMACOL,D-69120 HEIDELBERG,GERMANY
[5] UNIV HEIDELBERG,DEPT PAEDIAT,D-69120 HEIDELBERG,GERMANY
[6] UNIV TEXAS,SW MED CTR,DALLAS,TX 75235
关键词
D O I
10.1093/hmg/5.12.2039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid 21-hydroxylase deficiency is among the most common inborn errors of metabolism in man, Characterization of mutations in the 21-hydroxylase gene (CYP21) has permitted genetic diagnosis, facilitated by the polymerase chain reaction (PCR), The most common mutation is conversion of an A or C at nt656 to a G in the second intron causing aberrant splicing of mRNA. Homozygosity for nt656G is associated with profoundly deficient adrenal cortisol and aldosterone synthesis, secondary hypersecretion of adrenal androgens, and a severe form of congenital adrenal hyperplasia (CAH) characterized by ambiguous genitalia and/or sodium wasting in newborns, During the course of genetic analysis of CYP21 mutations in CAH families, we and others have noticed a number of relatives genotyped as nt656G homozygotes, yet showing no clinical signs of disease, A number of lines of evidence have led us to propose that the putative asymptomatic nt656G/G individuals are incorrectly typed due to dropout of one haplotype during PCR amplification of CYP21, For prenatal diagnosis, we recommend that microsatellite typing be used as a supplement to CYP21 genotyping in order to resolve ambiguities at nt656.
引用
收藏
页码:2039 / 2048
页数:10
相关论文
共 24 条
[2]   CLONING, OVEREXPRESSION AND NUCLEOTIDE-SEQUENCE OF A THERMOSTABLE DNA LIGASE-ENCODING GENE [J].
BARANY, F ;
GELFAND, DH .
GENE, 1991, 109 (01) :1-11
[3]   SCREENING OF CYP21 GENE-MUTATIONS IN 129 FRENCH PATIENTS AFFECTED BY STEROID 21-HYDROXYLASE DEFICIENCY [J].
BARBAT, B ;
BOGYO, A ;
RAUXDEMAY, MC ;
KUTTENN, F ;
BOUE, J ;
SIMONBOUY, B ;
SERRE, JL ;
BOUE, A ;
MORNET, E .
HUMAN MUTATION, 1995, 5 (02) :126-130
[4]  
BOERKOEL CF, 1995, AM J HUM GENET, V56, P887
[5]   TUMOR-NECROSIS-FACTOR MICROSATELLITES IN 4 EUROPEAN POPULATIONS [J].
CROUAUROY, B ;
BRIANT, L ;
BOUISSOU, C ;
STAVROPOULOS, C ;
POCIOT, F ;
CAMBONTHOMSEN, A ;
CLAYTON, J .
HUMAN IMMUNOLOGY, 1993, 38 (03) :213-216
[6]   DETECTION OF STEROID 21-HYDROXYLASE ALLELES USING GENE-SPECIFIC PCR AND A MULTIPLEXED LIGATION DETECTION REACTION [J].
DAY, DJ ;
SPEISER, PW ;
WHITE, PC ;
BARANY, F .
GENOMICS, 1995, 29 (01) :152-162
[7]   ALLELIC DROP-OUT AND PREFERENTIAL AMPLIFICATION IN SINGLE CELLS AND HUMAN BLASTOMERES - IMPLICATIONS FOR PREIMPLANTATION DIAGNOSIS OF SEX AND CYSTIC-FIBROSIS [J].
FINDLAY, I ;
RAY, P ;
QUIRKE, P ;
RUTHERFORD, A ;
LILFORD, R .
HUMAN REPRODUCTION, 1995, 10 (06) :1609-1618
[8]   THE 1993-94 GENETHON HUMAN GENETIC-LINKAGE MAP [J].
GYAPAY, G ;
MORISSETTE, J ;
VIGNAL, A ;
DIB, C ;
FIZAMES, C ;
MILLASSEAU, P ;
MARC, S ;
BERNARDI, G ;
LATHROP, M ;
WEISSENBACH, J .
NATURE GENETICS, 1994, 7 (02) :246-339
[9]   EFFECTS OF INDIVIDUAL MUTATIONS IN THE P-450(C21) PSEUDOGENE ON THE P-450(C21) ACTIVITY AND THEIR DISTRIBUTION IN THE PATIENT GENOMES OF CONGENITAL STEROID 21-HYDROXYLASE DEFICIENCY [J].
HIGASHI, Y ;
HIROMASA, T ;
TANAE, A ;
MIKI, T ;
NAKURA, J ;
KONDO, T ;
OHURA, T ;
OGAWA, E ;
NAKAYAMA, K ;
FUJIIKURIYAMA, Y .
JOURNAL OF BIOCHEMISTRY, 1991, 109 (04) :638-644
[10]   COMPLETE NUCLEOTIDE-SEQUENCE OF 2 STEROID 21-HYDROXYLASE GENES TANDEMLY ARRANGED IN HUMAN-CHROMOSOME - A PSEUDOGENE AND A GENUINE GENE [J].
HIGASHI, Y ;
YOSHIOKA, H ;
YAMANE, M ;
GOTOH, O ;
FUJIIKURIYAMA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2841-2845